Clinically Speaking with Dr. Wig: COVID-19 Vaccine Video Series
Operation Warp Speed, the name of the government project to produce and distribute 300 million doses of safe and effective vaccines to Americans, has been in the news since the beginning of COVID-19, and we’re finally seeing the fruits of those efforts in the form of vaccine announcements from Pfizer, Moderna and, most recently, AstraZeneca.
To make sense of this news, future vaccine updates, and other clinical topics impacting businesses, Evernorth invites you to join me for a new video series: Clinically Speaking with Dr. Wig. Our first videos are a primer of what we know to date and what you need to know about vaccine development, approval and distribution.
Sign up for our newsletter to get updates when new videos are available.
Speed + Safety
Today, roughly 30 of more than 300 COVID-19 vaccines in development are in human trials with a handful of promising candidates in phase 3 studies, the final phase before approval. Learn why the process is moving so quickly and how it’s being done safely.
While the speed at which vaccines are being developed is encouraging, there are four important considerations for moving forward—vaccine effectiveness, dosing, side effects and storage.
Approval + Distribution
Pfizer has already submitted an Emergency Use Authorization request with the FDA. Discover how the FDA is partnering with the health care ecosystem to streamline approvals, and when a vaccine might be available for high-risk patients and the general population.
While the world has been living with COVID-19 for more than a year, we’re just in the beginning phases of returning to a semblance of life pre-pandemic with the announcement of successful vaccine developments. Sign up for our newsletter to continue making sense of this and other clinical topics, as new videos become available.